RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Dynavax Technologies Stock

Dynavax Technologies P/E 2024

Dynavax Technologies P/E

104.06

Ticker

DVAX

ISIN

US2681582019

WKN

A12EV9

As of Dec 3, 2024, Dynavax Technologies's P/E ratio was 104.06, a -144.99% change from the -231.31 P/E ratio recorded in the previous year.

The Dynavax Technologies P/E history

Dynavax Technologies Aktienanalyse

What does Dynavax Technologies do?

Dynavax Technologies Corp is a US-based biotechnology company that specializes in developing innovative therapies and vaccines to combat infectious diseases and cancer. The company was founded in 1996 and is headquartered in Emeryville, California. Dynavax's roots can be traced back to the research work of Dr. Lawrence Steinman, a renowned immunologist at Stanford University. The company initially focused on researching autoimmune diseases such as multiple sclerosis and arthritis. In 2001, Dynavax received approval from the US Food and Drug Administration (FDA) for their first developed product called HEPLISAV, a hepatitis B vaccine. The company's business model is based on researching and developing therapies and vaccines based on immunology and genetics. Dynavax conducts intensive research in its laboratories to develop new treatment approaches and vaccines. The company collaborates closely with universities, government institutions, and other biotechnology companies to test and verify the effectiveness and safety of its products. Dynavax is divided into several divisions to oversee its product development and distribution activities. These divisions include vaccines, oncology, and autoimmune diseases. Dynavax has introduced several products to the market in recent years, including HEPLISAV, SD-101, AZD1419, and DYVAX FQ. The company continues to focus on researching and developing new therapies and vaccines. Dynavax Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Dynavax Technologies's P/E Ratio

The Price to Earnings (P/E) Ratio of Dynavax Technologies is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Dynavax Technologies's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Dynavax Technologies is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Dynavax Technologies’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Dynavax Technologies stock

What is the price-to-earnings ratio of Dynavax Technologies?

The price-earnings ratio of Dynavax Technologies is currently 104.06.

How has the price-earnings ratio of Dynavax Technologies changed compared to last year?

The price-to-earnings ratio of Dynavax Technologies has increased by -144.99% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Dynavax Technologies high compared to other companies?

Yes, the price-to-earnings ratio of Dynavax Technologies is high compared to other companies.

How does an increase in the price-earnings ratio of Dynavax Technologies affect the company?

An increase in the price-earnings ratio of Dynavax Technologies would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Dynavax Technologies affect the company?

A decrease in the price-earnings ratio of Dynavax Technologies would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Dynavax Technologies?

Some factors that influence the price-earnings ratio of Dynavax Technologies are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Dynavax Technologies pay?

Over the past 12 months, Dynavax Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Dynavax Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Dynavax Technologies?

The current dividend yield of Dynavax Technologies is .

When does Dynavax Technologies pay dividends?

Dynavax Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Dynavax Technologies?

Dynavax Technologies paid dividends every year for the past 0 years.

What is the dividend of Dynavax Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Dynavax Technologies located?

Dynavax Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Dynavax Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Dynavax Technologies from 12/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/3/2024.

When did Dynavax Technologies pay the last dividend?

The last dividend was paid out on 12/3/2024.

What was the dividend of Dynavax Technologies in the year 2023?

In the year 2023, Dynavax Technologies distributed 0 USD as dividends.

In which currency does Dynavax Technologies pay out the dividend?

The dividends of Dynavax Technologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Dynavax Technologies

Our stock analysis for Dynavax Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dynavax Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.